These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7867311)

  • 1. Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.
    Jones RN; Sader HS; Erwin ME
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):93-8. PubMed ID: 7867311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomefloxacin activity against 2,813 clinical isolates: a collaborative study at three medical centers in Brazil.
    Magalhaes M; Trabulsi LR; Montelli AC
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):35S-39S. PubMed ID: 2791496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
    Rossolini GM; Valentini S; Satta G
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
    Torres JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity.
    Jones RN
    Am J Med; 1992 Apr; 92(4A):52S-57S. PubMed ID: 1316072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.
    Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA
    Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
    Sader HS; Erwin ME; Jones RN
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):372-81. PubMed ID: 1327789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lomefloxacin: microbiologic assessment and unique properties.
    Mayer KH; Ellal JA
    Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of lomefloxacin activity in Colombia.
    Trujillo H; Mejia GI; Castrillon L; Gomez C
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE; Henderberg A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.
    Segreti J; Nelson JA; Goodman LJ; Kaplan RL; Trenholme GM
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1385-7. PubMed ID: 2802563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
    Stratton CW; Weeks LS
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):29S-34S. PubMed ID: 2791495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM; Lee GC; Ellis ME
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards].
    Aihara M; Oguri T; Kanno H; Kubo S; Honda M; Satoh K; Daimon Y; Yamanaka K; Sugawara K; Furuta T
    Rinsho Byori; 1992 Jan; 40(1):73-80. PubMed ID: 1312183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
    Cornaglia G; Ligozzi M; Pelosi E; Canepari P; Fontana R
    J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.